However, distant hematogenous metastases were not present, which is a key feature of FTC in humans [46]; this could potentially suggest that metastases may be triggered by another genetic mutation in the case of Prkar1a mutation in the thyroid. Here, PRKAR1A is linked to thyroid cancer, nonmedullary, 2.